Webinars
mRNA-A 20 Year Voyage to Patients
Summary: On December 13, 2021, EuropaBio hosted the final event of its 25th Anniversary programme with a focus on the story of mRNA.
View Now
Article
The New Normal: How the Supply Chain has Been Impacted by COVID-19
Summary: Supply chains have come under intense pressure, and companies have had to adapt to this “new normal” to avoid delays. During this Q&A, Catalent discusses....
View Now
Webinars
Women in BioPharma Awards 2021
Summary: Join us as we honor a group of 20 extraordinary women who are making lasting impacts in the drug development field.
View Now
Podcast
Leveraging N-1 Perfusion for Higher Productivity and Quality for Biologics
Summary: Join Claudia Berdugo, Ph.D., Director of Process Development at Catalent Biologics, for a podcast where she discusses N-1 perfusion and how Catalent Biologics works toward process improvements....
View Now
Webinars
Strategies to Accelerate the Path to Clinic for Next-Generation Antibodies
Summary: Experts discuss formulation development and purification strategies to increase throughput, reduce operating costs and decrease...
View Now
Article
What’s Next for mRNA? From COVID to Cancer & Beyond
Summary: During this Q&A, we discuss the challenges of mRNA development and manufacturing, potential solutions and where the industry may go next with mRNA therapies.
View Now
Webinars
Leveraging Proven Technology to Speed Path to First-In-Human Studies with GPEx® Lightning
Summary: During this talk, hear the latest data leveraging GPEx Lightning to generate highly stable, highly productive cell pools and discuss how the GPEx...
View Now
Webinars
How Lessons Learned from COVID-19 Pandemic Will Improve Vaccine Development in the Future
Summary: This webinar offers tips for incorporating elements of the successful COVID-19 vaccine rollout into future vaccine programs.
View Now
Offering Fact Sheet
Drug Substance Manufacturing Infocard
Summary: Catalent Biologics’ drug substance biomanufacturing services provide flexibility and scale to support your growth from clinical to commercial, with options to utilize single-use or stainless-steel bioreactors in a rigorous CGMP environment.
View Now
Webinars
Introducing GPEx® Lightning: Next Gen Cell Line Engineering to Speed Your Path to Clinic
Summary: During this talk, we share the latest data leveraging GPEx Lightning to generate highly stable, highly productive cell pools and discuss how the GPEx suite of technologies can be tailored to the specific needs of each individual program on its path to clinical trials.
View Now
